Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

Albemarle supports EPA efforts to address PBDEs



               Albemarle supports EPA efforts to address PBDEs

PR Newswire

BATON ROUGE, La., July 10, 2012

BATON ROUGE, La., July 10, 2012 /PRNewswire/ -- In a letter to Administrator
Lisa P. Jackson, Albemarle Corporation (NYSE: ALB) today offered its support
of the Environmental Protection Agency's efforts to finalize its proposed
actions on Polybrominated diphenyl ethers (PBDEs). Such action will ensure
that decaBDE will not be imported into the United States after December 31,
2013.

(Logo:  http://photos.prnewswire.com/prnh/20111129/MM14279LOGO )

In the letter, Dr. David Clary, Albemarle's Chief Sustainability Officer,
commented, "Albemarle supports the EPA proposal to amend the PBDE SNUR to
designate manufacturing, importing, or processing of decaBDE for any use which
is not ongoing after December 31, 2013 as a significant new use.  Further,
Albemarle supports the EPA's efforts to promulgate a test rule for PBDEs if it
determines that manufacture (including import) or processing of PBDEs has not
ceased by December 31, 2013."

Albemarle, in cooperation with the EPA, announced a voluntary phase out of its
production of decaBDE in 2009.  The company is on schedule to cease commercial
production of decaBDE entirely by the end of 2012 in accordance with its
agreement with EPA and will limit commercial sales within the United States in
2013 to only transportation and military applications requiring that
additional transition time.  

While many science-based and peer-reviewed studies have shown decaBDE to be
safe in its intended use, Albemarle is committed to delivering safe and
effective products with increasingly smaller environmental footprints.  The
company's proactive innovation has allowed it to bring two polymeric flame
retardants to market in the last few years:  GreenArmor and GreenCrest.  These
polymeric flame retardants, marketed under the Earthwise™ portfolio, represent
the latest fire safety technology and provide additional certainty about
product safety as they can't be absorbed by animal or human cells.  GreenCrest
has successfully completed review by EPA's New Chemicals Program and
GreenArmor has been submitted for such a review.

About Albemarle
Albemarle Corporation, headquartered in Baton Rouge, Louisiana, is a leading
global developer, manufacturer, and marketer of highly-engineered specialty
chemicals for consumer electronics, petroleum refining, utilities, packaging,
construction, automotive/transportation, pharmaceuticals, crop protection,
food-safety and custom chemistry services. The Company is committed to global
sustainability and is advancing its eco-practices and solutions in its three
business segments, Polymer Solutions, Catalysts and Fine Chemistry. Corporate
Responsibility Magazine selected Albemarle to its prestigious "100 Best
Corporate Citizens" list for 2010 and 2011.  Albemarle employs approximately
4,000 people and serves customers in approximately 100 countries. Albemarle
regularly posts information to www.albemarle.com, including notification of
events, news, financial performance, investor presentations and webcasts,
Regulation G reconciliations, SEC filings, and other information regarding the
Company, its businesses and the markets we serve.

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of
1995: Statements in this press release regarding Albemarle Corporation's
business that are not historical facts are "forward-looking statements" that
involve risks and uncertainties. For a discussion of such risks and
uncertainties, which could cause actual results to differ from those contained
in the forward-looking statements, see "Risk Factors" in the Company's Annual
Report on Form 10-K.

SOURCE Albemarle Corporation

Website: http://www.albemarle.com
Contact: Media Contact - Ashley Mendoza, +1-225-388-7137,
Ashley.Mendoza@albemarle.com; Investor Relations Contact - Lorin Crenshaw,
+1-225-388-7322, Lorin.Crenshaw@albemarle.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement